These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 20977160)

  • 1. The Vioxx pharmaceutical scandal: Peterson v Merke Sharpe & Dohme (Aust) Pty Ltd (2010) 184 FCR 1.
    Faunce T; Townsend R; McEwan A
    J Law Med; 2010 Sep; 18(1):38-49. PubMed ID: 20977160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An analysis of Australia's legal regime for imposing liability on manufacturers of pharmaceutical drugs.
    Tsui M
    J Law Med; 2014 Mar; 21(3):700-16. PubMed ID: 24804536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What have we learnt from Vioxx?
    Krumholz HM; Ross JS; Presler AH; Egilman DS
    BMJ; 2007 Jan; 334(7585):120-3. PubMed ID: 17235089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A message from the Vioxx case.
    Baldwin HJ; Droege M; Daniel KL
    Am J Health Syst Pharm; 2006 Mar; 63(6):503. PubMed ID: 16522877
    [No Abstract]   [Full Text] [Related]  

  • 5. US judge dismisses 50m dollars damages in Vioxx lawsuit.
    Charatan F
    BMJ; 2006 Sep; 333(7567):516. PubMed ID: 16960199
    [No Abstract]   [Full Text] [Related]  

  • 6. Court hears how drug giant Merck tried to "neutralise" and "discredit" doctors critical of Vioxx.
    Moynihan R
    BMJ; 2009 Apr; 338():b1432. PubMed ID: 19349350
    [No Abstract]   [Full Text] [Related]  

  • 7. The story of Vioxx--no pain and a lot of gain: ethical concerns regarding conduct of the pharmaceutical industry.
    Cahana A; Mauron A
    J Anesth; 2006; 20(4):348-51. PubMed ID: 17072707
    [No Abstract]   [Full Text] [Related]  

  • 8. Reducing injustice from recent legislation subsidising insurance and restricting civil liability?: Baker-Morrison v NSW [2009] Aust Torts Reports 81-999; Amaca Pty Ltd v Novek [2009] Aust Torts Reports 82-001.
    Faunce T; Townsend R; Reardon K
    J Law Med; 2010 May; 17(5):729-35. PubMed ID: 20552936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vioxx doctors wooed by Merck are now its foes.
    Tesoriero HW
    Wall St J (East Ed); 2006 Mar; ():B1, B3. PubMed ID: 16578911
    [No Abstract]   [Full Text] [Related]  

  • 10. Quebec allows Vioxx class-action suit.
    Sibbald B
    CMAJ; 2007 Jan; 176(1):20. PubMed ID: 17200378
    [No Abstract]   [Full Text] [Related]  

  • 11. Merck disguised "marketing publication" as medical journal to help promote Vioxx, court hears.
    Moynihan R
    BMJ; 2009 Apr; 338():b1714. PubMed ID: 19401326
    [No Abstract]   [Full Text] [Related]  

  • 12. The preacher who's raising hell with Merck.
    Parloff R
    Fortune; 2005 Aug; 152(3):20. PubMed ID: 16097189
    [No Abstract]   [Full Text] [Related]  

  • 13. Merck cleared in personal injury case against Vioxx.
    Mayor S
    BMJ; 2005 Nov; 331(7525):1101. PubMed ID: 16282390
    [No Abstract]   [Full Text] [Related]  

  • 14. Open conflict on the handling of the Merck drug Vioxx by editorial giants.
    Edwards RG
    Reprod Biomed Online; 2006 Dec; 13(6):905. PubMed ID: 17169217
    [No Abstract]   [Full Text] [Related]  

  • 15. Merck defends Vioxx in court, as publisher apologises for fake journal.
    Moynihan R
    BMJ; 2009 May; 338():b1914. PubMed ID: 19433504
    [No Abstract]   [Full Text] [Related]  

  • 16. Court awards claimant 13.5m dollars in rofecoxib lawsuit.
    Tanne JH
    BMJ; 2006 Apr; 332(7547):927. PubMed ID: 16627492
    [No Abstract]   [Full Text] [Related]  

  • 17. The Vioxx® legacy: Enduring lessons from the not so distant past.
    McIntyre WF; Evans G
    Cardiol J; 2014; 21(2):203-5. PubMed ID: 24752949
    [No Abstract]   [Full Text] [Related]  

  • 18. 94% of patients suing Merck over rofecoxib agree to company's offer.
    Charatan F
    BMJ; 2008 Mar; 336(7644):580-1. PubMed ID: 18340064
    [No Abstract]   [Full Text] [Related]  

  • 19. Hippocratic obligation to shareholder profit? Medical treatment patents and the Australian High Court in Apotex Pty Ltd v Sanofi-Aventis Australia Pty Ltd [2013] HCA 50.
    Vines T
    J Law Med; 2014 Jun; 21(4):797-809. PubMed ID: 25087362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How the New England Journal missed warning signs on Vioxx: medical weekly waited years to report flaws in article that praised pain drug; Merck seen as "punching bag".
    Armstrong D
    Wall St J (East Ed); 2006 May; ():A1, A10. PubMed ID: 16848016
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.